Statistics

Total Visits

Views
Phase II study of dovitinib in first line metastatic or (nonresectable primary) adrenocortical carcinoma (ACC): SOGUG study 2011-0310

Select a period of time:

Number of views in the range

Views
Phase II study of dovitinib in first line metastatic or (nonresectable primary) adrenocortical carcinoma (ACC): SOGUG study 2011-036

Views

Views
May 20241
June 20241
July 20243
August 20241
September 20240
October 20240
November 20240
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States5
Netherlands1
 

Top cities views

Views
Amsterdam1